Skip to main content
    • Aa
    • Aa
  • Get access
    Check if you have access via personal or institutional login
  • Cited by 12
  • Cited by
    This article has been cited by the following publications. This list is generated based on data provided by CrossRef.

    Zarfel, Gernot Luxner, Josefa Folli, Bettina Leitner, Eva Feierl, Gebhard Kittinger, Clemens Grisold, Andrea and Enright, Mark 2016. Increase of genetic diversity and clonal replacement of epidemic methicillin-resistantStaphylococcus aureusstrains in South-East Austria. FEMS Microbiology Letters, Vol. 363, Issue. 14, p. fnw137.

    Williamson, D.A. Coombs, G.W. and Nimmo, G.R. 2014. Staphylococcus aureus ‘Down Under’: contemporary epidemiology of S. aureus in Australia, New Zealand, and the South West Pacific. Clinical Microbiology and Infection, Vol. 20, Issue. 7, p. 597.

    Fernandez, S. de Vedia, L. Lopez Furst, M.J. Gardella, N. Di Gregorio, S. Ganaha, M.C. Prieto, S. Carbone, E. Lista, N. Rotrying, F. Stryjewski, M.E. and Mollerach, M. 2013. Methicillin-resistant Staphylococcus aureus ST30-SCCmec IVc clone as the major cause of community-acquired invasive infections in Argentina. Infection, Genetics and Evolution, Vol. 14, p. 401.

    Aneja, Rajesh K. Varughese-Aneja, Ruby Vetterly, Carol G. and Carcillo, Joseph A. 2011. Antibiotic Therapy in Neonatal and Pediatric Septic Shock. Current Infectious Disease Reports, Vol. 13, Issue. 5, p. 433.

    Chua, K. Laurent, F. Coombs, G. Grayson, M. L. and Howden, B. P. 2011. Not Community-Associated Methicillin-Resistant Staphylococcus aureus (CA-MRSA)! A Clinician's Guide to Community MRSA - Its Evolving Antimicrobial Resistance and Implications for Therapy. Clinical Infectious Diseases, Vol. 52, Issue. 1, p. 99.

    Bartels, M.D. Kristoffersen, K. Boye, K. and Westh, H. 2010. Rise and subsequent decline of community-associated methicillin resistant Staphylococcus aureus ST30-IVc in Copenhagen, Denmark through an effective search and destroy policy. Clinical Microbiology and Infection, Vol. 16, Issue. 1, p. 78.

    Böcher, S. Skov, R.L. Knudsen, M.A. Guardabassi, L. Mølbak, K. Schouenborg, P. Sørum, M. and Westh, H. 2010. The search and destroy strategy prevents spread and long-term carriage of methicillin-resistant Staphylococcus aureus: results from the follow-up screening of a large ST22 (E-MRSA 15) outbreak in Denmark. Clinical Microbiology and Infection, Vol. 16, Issue. 9, p. 1427.

    Shabir, S. Hardy, K. J. Abbasi, W. S. McMurray, C. L. Malik, S. A. Wattal, C. and Hawkey, P. M. 2010. Epidemiological typing of meticillin-resistant Staphylococcus aureus isolates from Pakistan and India. Journal of Medical Microbiology, Vol. 59, Issue. 3, p. 330.

    Hidron, Alicia I Low, Cari E Honig, Eric G and Blumberg, Henry M 2009. Emergence of community-acquired meticillin-resistant Staphylococcus aureus strain USA300 as a cause of necrotising community-onset pneumonia. The Lancet Infectious Diseases, Vol. 9, Issue. 6, p. 384.

    Francois, Patrice Harbarth, Stephan Huyghe, Antoine Renzi, Gesuele Bento, Manuela Gervaix, Alain Pittet, Didier and Schrenzel, Jacques 2008. Methicillin-ResistantStaphylococcus aureus, Geneva, Switzerland, 1993–2005. Emerging Infectious Diseases, Vol. 14, Issue. 2, p. 304.

    Grinberg, A Kingsbury, DD Gibson, IR Kirby, BM Mack, HJ and Morrison, D 2008. Clinically overt infections with methicillin-resistantStaphylococcus aureusin animals in New Zealand: A pilot study. New Zealand Veterinary Journal, Vol. 56, Issue. 5, p. 237.

    Tong, Steven Y. C. McDonald, Malcolm I. Holt, Deborah C. and Currie, Bart J. 2008. Global Implications of the Emergence of Community‐Associated Methicillin‐ResistantStaphylococcus aureusin Indigenous Populations. Clinical Infectious Diseases, Vol. 46, Issue. 12, p. 1871.


A decade of community MRSA in New Zealand

  • J. M. B. SMITH (a1) and G. M. COOK (a1)
  • DOI:
  • Published online: 01 April 2005

In 1992, isolates with a distinctive phage pattern were identified amongst the 186 MRSA recovered in New Zealand. These unusual isolates were recovered in the Auckland region from individuals who came from or had visited Western Samoa, and were called Western Samoan phage pattern (WSPP) MRSA. They were almost exclusively community based and were mainly responsible for the alarming 15-fold increase in MRSA seen in New Zealand over the next 6 years. Since 2000, the number of infections attributable to WSPP MRSA appears to be declining. WSPP isolates are clonal, possess a unique type IV SCCmec element, and a distinctive multilocus sequence allelic profile (ST30). WSPP isolates are invariably not multiresistant with methicillin MICs generally [les ]32 μg/ml. Virulence of the WSPP clone appears to be related to its adhesive and consistent toxin- (e.g. Panton–Valentine leukocidin, α- and γ-haemolysins) producing capabilities. Isolates are most frequently associated with cutaneous lesions in younger age groups. Since 1998, MRSA isolates belonging to the UK-derived EMRSA-15 strain (also type IV SCCmec) have continued to increase in New Zealand, and together with WSPP, these strains now dominate MRSA isolations in New Zealand.

Corresponding author
Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

Epidemiology & Infection
  • ISSN: 0950-2688
  • EISSN: 1469-4409
  • URL: /core/journals/epidemiology-and-infection
Please enter your name
Please enter a valid email address
Who would you like to send this to? *